Clinical Trial

Effects of Berberine on the Human Gut Microbiome

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Berberine hydrochloride is a conventional component in Chinese medicine. In recent years, anticancer activity of berberine hydrochloride have been explored. The aim of this study is to investigate the effect of berberine hydrochloride on the human gut microbiome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-06.
Trial Details
NCT Number NCT07519681
Lead Sponsor Jing-yuan Fang, MD, Ph. D
Collaborators: Shanghai Jiao Tong University School of Medicine
Conditions Colorectal Adenomas, Colorectal Cancers
Enrollment 20 participants
Start Date 2026-05-15
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-11